Home > Practice > Current Affairs > September - 2024 > September 14, 2024
1. In which continent has the WHO granted approval for its first Mpox vaccine for adults?
The World Health Organization (WHO) has recently granted approval for its first Mpox vaccine specifically for use in Africa. This vaccine, developed by Bavarian Nordic A/S, represents a significant advancement in addressing Mpox, particularly in the African region. The approval allows for the vaccine's pre-qualification for purchase by international donors such as GAVI and UNICEF. Despite its limited supply due to a single manufacturer, this development is a critical step in controlling outbreaks and improving public health in Africa.